Guardant Health, Inc. provided revenue guidance for full year 2023. For the period, the company expects revenue to be in the range of $553 to $556 million, representing growth of 23% to 24% compared to full year 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.37 USD | +15.07% | +18.49% | -17.30% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.30% | 2.73B | |
-27.67% | 9.87B | |
-11.15% | 2.24B | |
-22.32% | 1.63B | |
+59.69% | 1.39B | |
+23.58% | 771M | |
-1.31% | 760M | |
-28.57% | 516M | |
+5.37% | 310M | |
+12.46% | 219M |
- Stock Market
- Equities
- GH Stock
- News Guardant Health, Inc.
- Guardant Health, Inc. Provides Revenue Guidance for Full Year 2023